Golli-MBP gene in multiple sclerosis susceptibility

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 158-167

  Tienari, Pentti J ^a,b   Kuokkanen, Satu ^a   Pastinen, Tomi ^a   Wikström, Juhani ^b   Sajantila, Antti ^a   Sandberg Wollheim, Magnhild ^c   Palo, Jorma ^b   Peltonen, Leena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Genetics; Insulin dependent diabetes mellitus; Multiple sclerosis; Myelin basic protein; Repetitive sequence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FINLAND; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN;

EID: 0031837738     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00171-9     Document Type: Article

References (41)

1. Bennet S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Neurp J., Bouzekri N., Cambon-Thomsen A., Ronningen K.S., Barnett A.H., Bain S.C., Todd J.A. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9:1995;284-292.
2. Boylan K.B., Takahashi N., Paty D.W., Sadovnick A.D., Diamond M., Hood L.E., Prusiner S.B. DNA length polymorphism 5′ to the myelin basic protein gene is associated with multiple sclerosis. Ann. Neurol. 27:1990;291-297.
3. n 5′ to the human myelin basic protein gene: a new form of oligonucleotide repetitive sequence showing length polymorphism. Genomics. 6:1990;16-22.
4. Deber C.M., Reynolds S.J. Central nervous system myelin: structure, function, and pathology. Clin. Biochem. 24:1991;113-134.
5. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1994;1-17.
6. Ebers, G.C., Sadovnick, A.D., Risch, N.J., Canadian Collaborative Study Group, 1995. A genetic basis for familial aggregation of multiple sclerosis. Nature 377, 150-151.
7. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.-P., Hinds D., Risch N. A full genome screen in multiple sclerosis. Nat. Genet. 13:1996;472-476.
8. Eoli M., Pandolfo M., Milanese C., Gasparini P., Salmaggi A.A., Zeviani M. The myelin basic protein gene is not a major susceptibility locus for multiple sclerosis in Italian patients. J. Neurol. 241:1994;615-619.
9. Graham C.A., Kirk C.W., Nevin N.C., Droogan A.G., Hawkins S.A., McMillan S.A., McNeill T.A. Lack of association between myelin basic protein gene microsatellite and multiple sclerosis. Lancet. 341:1993;1596.
10. Harding A.E., Sweeney M.G., Miller D.H., Mumford C.J., Kellar-Wood H., Menard D., McDonald W.I., Compston D.A. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial mutation. Brain. 115:1992;979-989.
11. Ibsen S.N., Clausen J. A repetitive DNA sequence 5′ to the human myelin basic protein gene may be linked to MS in Danes. Acta Neurol. Scand. 93:1996;236-240.
12. Kamholz J., Toffenetti J., Lazzarini R.A. Organization and expression of the human myelin basic protein gene. J. Neurosci. Res. 21:1988;62-70.
13. Kauppinen R., Mustajoki S., Pihlaja H., Peltonen L., Mustajoki P. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. Hum. Mol. Genet. 4:1995;215-222.
14. Kellar-Wood H.F., Wood N.W., Holmans P., Clayton D., Robertson N., Compston D.A.S. Multiple sclerosis and the HLA-D region: linkage and association studies. J. Neuroimmunol. 58:1995;183-190.
15. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:1993;2602-2608.
16. Kuokkanen S., Sundvall M., Terwilliger J.D., Tienari P.J., Wikström J., Holmdahl R., Petterson U., Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13:1996;477-480.
17. The Multiple Sclerosis Genetics Group, 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13, 469-471.
18. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
19. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics. 5:1989;874-879.
20. Polymeropoulos M.H., Xiao H., Merril C.R. Tetranucleotide repeat polymorphism at the human myelin basic protein gene (MBP). Hum. Mol. Genet. 1:1992;658.
21. Pribyl T.M., Campagnoni C.W., Kampf K., Kashima T., Handley V.W., McMahon J., Campagnoni A.T. The human myelin basic protein gene is included within a 179-kilobase transcription unit: Expression in the immune and central nervous systems. Proc. Natl. Acad. Sci. USA. 90:1993;10695-10699.
22. Pugliese A., Zeller M., Fernandez A. Jr., Zalcberg L.J., Bartlett R.J., Ricordi C., Pietropaolo M., Eisenbarth G.S., Bennett S.T., Patel D.D. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15:1997;293-297.
23. Raine C.S. The Norton lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77:1997;135-152.
24. Rose J., Gerken S., Lynch S., Pisani P., Varvil T., Otterud B., Leppert M. Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet. 341:1993;1179-1181.
25. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
26. Streicher R., Stoffel W. The organisation of the human myelin basic protein gene: comparison with the mouse gene. Biol. Chem. Hoppe Seiler. 370:1989;503-510.
27. Lys point mutation in myoclonus epilepsy and ragged-red-fiber disease. Eur. J. Hum. Genet. 1:1993;88-95.
28. Tautz D., Schlötterer C. Simple sequences. Curr. Opin. Genet. Dev. 4:1994;832-837.
29. Terwilliger, J.D. and Ott, J. (1994) A Handbook of Genetic Linkage. Johns Hopkins University Press, Baltimore, MD.
30. Tienari P.J., Wikström J., Sajantila A., Palo J., Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet. 340:1992;987-991.
31. Tienari P.J., Salonen O., Wikström J., Valanne L., Palo J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J. Neurol. Neurosurg. Psychiatry. 55:1992;883-886.
32. Tienari P.J., Wikström J., Koskimies S., Partanen J., Palo J., Peltonen L. Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families. Eur. J. Hum. Genet. 1:1993;257-268.
33. Tienari P.J. Multiple sclerosis: multiple etiologies, multiple genes? Ann. Med. 26:1994;259-269.
34. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., Wickramasinghe S., Colle E., Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15:1997;289-292.
35. Vandevyver C., Stinissen P., Cassiman J.J., Raus J. Myelin basic protein gene is not associated with chronic progressive multiple sclerosis. J. Neuroimmunol. 52:1994;97-99.
36. Wansen, K., Pastinen, T., Kuokkanen, S., Wikström, J., Palo, J., Peltonen, L., Tienari, P.J., 1997. Immune system genes in multiple sclerosis: Genetic association and linkage analyses on TCRVβ, IGH, IFN-γ and IL-1ra/IL-1β loci. J. Neuroimmunol., in press.
37. Weber J.L., Wong C. Mutation of human short tandem repeats. Hum. Mol. Genet. 2:1993;1123-1128.
38. Wikström J., Kinnunen E., Porras J. The age-specific prevalence ratio of familial multiple sclerosis. Neuroepidemiology. 3:1984;74-82.
39. Wood N.W., Holmans P., Clayton D., Robertson N., Compston D.A.S. No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairs. J. Neurol. Neurosurg. Psychiatry. 57:1994;1191-1194.
40. Voskuhl R., McFarlin D., Tranquill L., Deibler G., Stone R., Maloni H., McFarland H.F. A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination. J. Neuroimmunol. 46:1993;137-144.
41. Wucherpfennig K.W., Weiner H.L., Hafler D.A. T-cell recognition of myelin basic protein. Immunol. Today. 12:1991;277-282.